Quidel Corp (QDEL) Misses Q1 EPS by 33c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall St treads water as chips rise, megacaps fall ahead of Fed, Big Tech earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise about 2% as Yemen fighting stokes supply fears
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
Quidel Reports First Quarter 2021 Financial Results
May 6, 2021 4:10 PM EDTSAN DIEGO--(BUSINESS WIRE)-- Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the first quarter ended March 31, 2021.
First Quarter 2021 Highlights
Total revenue increased 115% to $375.3 million, from $174.7 million in the first quarter of 2020. Total sales of COVID-19 products were $280.3 million, as compared to $1.0 million in the first quarter of 2020. Total sales of Influenza products were $5.2 million, as compared to $79.6 million in the first quarter of 2020. Cardiometabolic Immunoassay sales... More


